TY  - JOUR
PY  - 2006//
TI  - Substance use, suicidality, and adolescent-onset schizophrenia: an Israeli 10-year retrospective study
JO  - Journal of child and adolescent psychopharmacology
A1  - Shoval, Gal
A1  - Sever, J.
A1  - Sher, Leo
A1  - Diller, Robyne
A1  - Apter, Alan
A1  - Weizman, Abraham
A1  - Zalsman, Gil
SP  - 767
EP  - 775
VL  - 16
IS  - 6
N2  - Objective: The aim of this study was to investigate the link between the use of specific types of substances and suicidality in adolescent inpatients with schizophrenia and schizoaffective disorder. Methods: We performed a 10-year naturalistic retrospective study of 178 adolescent inpatients diagnosed as suffering from either schizophrenia or schizoaffective disorder. A comparison was made between the suicide-attempting adolescent inpatients and the non-attempting subjects, by the use of specific types of substances, measurements of psychotic, depressive, and aggressive symptoms, and clinical data reported during their hospitalization. Results: The suicide attempters reported considerably greater usage of inhalants and lysergic acid diethylamide (LSD). Alcohol and methylene-dioxy-methylamphethamine (MDMA) were also used significantly more by this group. However, no differences were found in the usage of cannabis, amphethamines, cocaine, and opiates. The suicide-attempting patients were found to have had more previous psychiatric admissions, a greater level of deliberate self-harm behavior, and a higher level of suicide ideation, but a decreased severity of psychotic symptoms. Conclusions: This study is the first report of the association between specific types of substances and suicidality in the high-risk population of adolescent psychotic inpatients. The strong association between inhalants, LSD, alcohol, and MDMA with suicidality is relevant to suicide prevention and intervention programs in adolescent-onset schizophrenia.<p />  <p>Language: en</p>
LA  - en
SN  - 1044-5463
UR  - http://dx.doi.org/10.1089/cap.2006.16.767
ID  - ref1
ER  -